137 related articles for article (PubMed ID: 390422)
21. Peripheral arterial disease: drug therapy.
Schwartz JB
J Gend Specif Med; 2002; 5(4):16-20. PubMed ID: 12192882
[No Abstract] [Full Text] [Related]
22. [Medical and surgical therapeutic indications in peripheral arterial obliterations caused by arteriosclerosis].
Fontaine R; Fontaine JL
Minerva Med; 1967 Dec; 58(101):4648-55. PubMed ID: 6082165
[No Abstract] [Full Text] [Related]
23. Management of the patient with acute stroke.
Greer M
Geriatrics; 1973 Dec; 28(12):48-53. PubMed ID: 4758650
[No Abstract] [Full Text] [Related]
24. [Apoplexy- -differential diagnosis and therapy].
Eisenblätter-Voigt D
Z Alternsforsch; 1975; 30(2):143-58. PubMed ID: 1226819
[No Abstract] [Full Text] [Related]
25. [Defibrination with ancrod (arvin) in peripheral arterial occlusive diseases. Principle, indications, contraindications technic and course].
Heidrich H
ZFA (Stuttgart); 1978 Nov; 54(32):1648-51. PubMed ID: 735320
[No Abstract] [Full Text] [Related]
26. [Medical treatment of obliterative arteritis of the lower limbs].
Megret G
Soins Cardiol; 1985; (30-31):28-31. PubMed ID: 3852455
[No Abstract] [Full Text] [Related]
27. [Digitalis therapy in arterial occlusive diseases].
Brecht T; Bodem G; Schäfer E
Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1943-6. PubMed ID: 1030143
[No Abstract] [Full Text] [Related]
28. [Microcirculation in peripheral arterial occlusive diseases will improve. Prostaglandin can prevent surgery].
MMW Fortschr Med; 2003 Dec; 145(51-52):41. PubMed ID: 14974333
[No Abstract] [Full Text] [Related]
29. Medical management of chronic occlusive arterial disease.
Chucker F
Angiology; 1977 Nov; 28(11):760-9. PubMed ID: 333994
[No Abstract] [Full Text] [Related]
30. Batroxobin plus aspirin reduces restenosis after angioplasty for arterial occlusive disease in diabetic patients with lower-limb ischemia.
Wang J; Zhu YQ; Li MH; Zhao JG; Tan HQ; Wang JB; Liu F; Cheng YS
J Vasc Interv Radiol; 2011 Jul; 22(7):987-94. PubMed ID: 21570870
[TBL] [Abstract][Full Text] [Related]
31. [Improvement of walking disability and conservative treatment. Guiding principles for drug treatment of chronic arterial occlusive disease (stage I and IIb)].
Heinrich F
Fortschr Med; 1984 Sep; 102(36):74-5. PubMed ID: 6489898
[No Abstract] [Full Text] [Related]
32. [Medical therapy of peripheral arteriopathies].
Antignani PL
Clin Ter; 1984 Feb; 108(4):339-43. PubMed ID: 6232072
[No Abstract] [Full Text] [Related]
33. Antithrombotic therapy in peripheral arterial occlusive disease.
Jackson MR; Clagett GP
Chest; 2001 Jan; 119(1 Suppl):283S-299S. PubMed ID: 11157655
[No Abstract] [Full Text] [Related]
34. [Arterial embolism of the extremities. Bases for its treatment].
Tamames Escobar S
An R Acad Nac Med (Madr); 1989; 106(4):587-604. PubMed ID: 2701207
[No Abstract] [Full Text] [Related]
35. [Principles of pathogenetic treatment of patients with obliterating arterial diseases of the extremities].
Mizun PG
Sov Med; 1973 Oct; 36(10):18-23. PubMed ID: 4789211
[No Abstract] [Full Text] [Related]
36. [Chronic peripheral obliterating arteriopathies (CPOA) of the lower limbs].
Ghiringhelli C; Montorsi M
Minerva Med; 1980 Jun; 71(26):1833-64. PubMed ID: 7393468
[No Abstract] [Full Text] [Related]
37. [Defibrination with the snake venom enzyme arwin in peripheral arterial obstructive disease. Possibilities and limitations (author's transl)].
Böhme H; Schmidt P; Hüttel E
MMW Munch Med Wochenschr; 1978 Nov; 120(45):1501-4. PubMed ID: 101819
[TBL] [Abstract][Full Text] [Related]
38. [Physiopathology and therapy of obliterating arteriopathies].
Schettler G; Mörl H
Clin Ter; 1979 Jan; 88(1):3-19. PubMed ID: 436376
[No Abstract] [Full Text] [Related]
39. [Letter: Therapeutic defibrination with Ancrod].
Ehrly AM
Dtsch Med Wochenschr; 1974 Jan; 99(3):112-3. PubMed ID: 4812781
[No Abstract] [Full Text] [Related]
40. Clinical experience with Ancrod in acute ischaemic stroke.
Nuber R
Cerebrovasc Dis; 2000; 10 Suppl 4():27-9. PubMed ID: 11070397
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
